rs4572871

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001077207.4(SEC31A):​c.2968+2406T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.66 in 152,174 control chromosomes in the GnomAD database, including 35,930 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.66 ( 35930 hom., cov: 33)

Consequence

SEC31A
NM_001077207.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.95

Publications

11 publications found
Variant links:
Genes affected
SEC31A (HGNC:17052): (SEC31 homolog A, COPII coat complex component) The protein encoded by this gene shares similarity with the yeast Sec31 protein, and is a component of the outer layer of the coat protein complex II (COPII). The encoded protein is involved in vesicle budding from the endoplasmic reticulum (ER) and contains multiple WD repeats near the N-terminus and a proline-rich region in the C-terminal half. It associates with the protein encoded by the SEC13 homolog, nuclear pore and COPII coat complex component (SEC13), and is required for ER-Golgi transport. Monoubiquitylation of this protein by CUL3-KLHL12 was found to regulate the size of COPII coats to accommodate unusually shaped cargo. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
SEC31A Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with spastic quadriplegia, optic atrophy, seizures, and structural brain anomalies
    Inheritance: AR, Unknown Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.787 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001077207.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SEC31A
NM_001077207.4
MANE Select
c.2968+2406T>C
intron
N/ANP_001070675.1O94979-1
SEC31A
NM_001400154.1
c.3061+2406T>C
intron
N/ANP_001387083.1D6REX3
SEC31A
NM_001400155.1
c.3061+2406T>C
intron
N/ANP_001387084.1D6REX3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SEC31A
ENST00000395310.7
TSL:1 MANE Select
c.2968+2406T>C
intron
N/AENSP00000378721.2O94979-1
SEC31A
ENST00000508502.5
TSL:1
c.2923+2451T>C
intron
N/AENSP00000424635.1O94979-2
SEC31A
ENST00000348405.8
TSL:1
c.2851+2406T>C
intron
N/AENSP00000337602.5O94979-4

Frequencies

GnomAD3 genomes
AF:
0.661
AC:
100456
AN:
152056
Hom.:
35920
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.370
Gnomad AMI
AF:
0.864
Gnomad AMR
AF:
0.779
Gnomad ASJ
AF:
0.783
Gnomad EAS
AF:
0.512
Gnomad SAS
AF:
0.697
Gnomad FIN
AF:
0.765
Gnomad MID
AF:
0.747
Gnomad NFE
AF:
0.793
Gnomad OTH
AF:
0.705
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.660
AC:
100495
AN:
152174
Hom.:
35930
Cov.:
33
AF XY:
0.661
AC XY:
49158
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.369
AC:
15324
AN:
41518
American (AMR)
AF:
0.779
AC:
11913
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.783
AC:
2717
AN:
3470
East Asian (EAS)
AF:
0.512
AC:
2651
AN:
5174
South Asian (SAS)
AF:
0.698
AC:
3370
AN:
4828
European-Finnish (FIN)
AF:
0.765
AC:
8093
AN:
10574
Middle Eastern (MID)
AF:
0.752
AC:
221
AN:
294
European-Non Finnish (NFE)
AF:
0.793
AC:
53927
AN:
68004
Other (OTH)
AF:
0.707
AC:
1491
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1471
2942
4412
5883
7354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
780
1560
2340
3120
3900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.713
Hom.:
8047
Bravo
AF:
0.650
Asia WGS
AF:
0.632
AC:
2191
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
15
DANN
Benign
0.65
PhyloP100
2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4572871; hg19: chr4-83760887; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.